Coen R N Rasch
Overview
Explore the profile of Coen R N Rasch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van der Ree M, Dieleman E, Visser J, Planken R, Boekholdt S, de Bruin-Bon R, et al.
Europace
. 2023 Feb;
25(3):1015-1024.
PMID: 36746553
Aims: Stereotactic arrhythmia radiotherapy (STAR) is suggested as potentially effective and safe treatment for patients with therapy-refractory ventricular tachycardia (VT). However, the current prospective knowledge base and experience with STAR...
12.
Jaarsma-Coes M, Klaassen L, Verbist B, Vu T, Klaver Y, Rodrigues M, et al.
Adv Radiat Oncol
. 2023 Jan;
8(3):101149.
PMID: 36691449
Purpose: Several efforts are being undertaken toward MRI-based treatment planning for ocular proton therapy for uveal melanoma (UM). The interobserver variability of the gross target volume (GTV) on magnetic resonance...
13.
Klaassen L, Jaarsma-Coes M, Verbist B, Vu T, Marinkovic M, Rasch C, et al.
Phys Imaging Radiat Oncol
. 2022 Nov;
24:102-110.
PMID: 36386446
Background And Purpose: Three-dimensional (3D) Magnetic Resonance Imaging (MRI) is increasingly used to complement conventional two-dimensional ultrasound in the assessment of tumour dimension measurement of uveal melanoma. However, the lack...
14.
15.
Jaarsma-Coes M, Ferreira T, Marinkovic M, Vu T, van Vught L, van Haren G, et al.
Ophthalmol Retina
. 2022 Jul;
7(2):178-188.
PMID: 35840053
Objective: Conventionally, ocular proton therapy (PT) is planned using measurements obtained by an ophthalmologist using ultrasound, fundoscopy, biometry, and intraoperative assessments. Owing to the recent advances in magnetic resonance imaging...
16.
Nuijens A, Oei A, Bouhuijs A, Franken N, Rasch C, Stalpers L
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406443
Patient-reported outcome measures (PROMs) are advocated for the monitoring of toxicity after radiotherapy. However, studies comparing physician- and patient-reported toxicity show low concordance. In this study, we compared physician- and...
17.
Bakker A, Valverde C, van Tienhoven G, Kolff M, Kok H, Slotman B, et al.
Radiother Oncol
. 2022 Jan;
167:149-157.
PMID: 34973278
Purpose: To investigate the impact of hyperthermia thermal dose (TD) on locoregional control (LRC), overall survival (OS) and toxicity in locoregional recurrent breast cancer patients treated with postoperative re-irradiation and...
18.
Marinkovic M, Pors L, van den Berg V, Peters F, Schalenbourg A, Zografos L, et al.
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944862
Objective: To assess oncological and ophthalmological outcomes after international referral of uveal melanoma patients for proton therapy. Materials And Methods: This is a retrospective study among Dutch uveal melanoma patients...
19.
Nuijens A, Oei A, van Oorschot B, Visser J, van Os R, Moerland P, et al.
Int J Radiat Oncol Biol Phys
. 2021 Aug;
112(1):212-221.
PMID: 34419566
Purpose: Late radiation toxicity is a major dose-limiting factor in curative cancer radiation therapy. Previous studies identified several risk factors for late radiation toxicity, including both dose-volume factors and genetic...
20.
Jaarsma-Coes M, Marinkovic M, Astreinidou E, Schuurmans M, Peters F, Luyten G, et al.
Phys Imaging Radiat Oncol
. 2021 Jan;
16:33-36.
PMID: 33458341
Proton beam therapy (PBT) for uveal melanoma (UM) is performed in sitting position, while the acquisition of the Magnetic resonance (MR)-images for treatment planning is performed in supine position. We...